Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Cash Flows from Operating Activities:
Net income	$ 6,668	$ 3,399
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	1,954	810
Provision for bad debts (for cash flow statement)	4,044	500
Stock issued for costs and expenses	155
Compensatory element of stock issuances	86	147
Stock option Exercised	31
(Increase) decrease in operating assets, net:
Accounts, management fee and medical receivables	(7,261)	(1,773)
Notes receivable	60	67
Costs and estimated earnings in excess of billings on uncompleted contracts	(609)	382
Inventories	(485)	(44)
Prepaid expenses and other current assets	210	(44)
Other assets	42	(23)
Increase (decrease) in operating liabilities, net:
Accounts payable	189	(94)
Other current liabilities	1,580	602
Customer advances	183	257
Other liabilities	(58)	(22)
Due to related medical practices	(2)	1
Income tax payable	(20)	(100)
Net cash provided by operating activities	6,767	4,065
Cash Flows from Investing Activities:
Purchases of property and equipment	(277)	(276)
Cost of patents	(58)	(62)
Net cash used in investing activities	(335)	(338)
Cash Flows from Financing Activities:
Repayment of borrowings and capital lease obligations	(2,195)	(514)
Distributions to non controlling interests	(2,696)	(497)
Repayment of notes receivable from employee Stockholders	13	12
Net cash provided by (used in) financing activities	(4,878)	(999)
Net (Decrease) Increase in Cash and Cash Equivalents	1,554	2,728
Cash and Cash Equivalents - Beginning of Period	7,871	12,032
Cash and Cash Equivalents - End of Period	$ 9,425	$ 14,760